Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00386672 · ClinicalTrials.gov registry record · NA
Calcium Supplementation for a Healthy Weight-Lite (CaSHeW Lite)
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 83
- Enrollment target
NCT00386672: Completed NA study, sponsored by Massachusetts General Hospital.
NCT00386672 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 83 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00386672, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 83 participants
- Enrollment target
Study Summary
The purpose of the study is to find out if taking calcium and vitamin D supplements, while following a low-calorie diet, can help people lose weight.
Interventions
- BEHAVIORAL Nutrition Counseling
- DIETARY_SUPPLEMENT Reduced energy (lite) OJ fortified with Calcium and Vitamin D
- DIETARY_SUPPLEMENT Reduced energy (lite) OJ without Calcium and Vitamin D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2006-05 |
| Est. Completion | 2006-12 |
| Phase | NA |
What the finished NCT00386672 record still lists
NCT00386672 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 83 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 3 interventions - of which Nutrition Counseling is the first listed.
NCT00386672 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00386672 about?
NCT00386672 is a clinical study titled "Calcium Supplementation for a Healthy Weight-Lite (CaSHeW Lite)". The purpose of the study is to find out if taking calcium and vitamin D supplements, while following a low-calorie diet, can help people lose weight.
What is the current status of trial NCT00386672?
This trial is currently completed. It is a NA study. The enrollment target is 83 participants. The study started on 2006-05. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00386672?
The interventions under investigation include: Nutrition Counseling (BEHAVIORAL), Reduced energy (lite) OJ fortified with Calcium and Vitamin D (DIETARY_SUPPLEMENT), Reduced energy (lite) OJ without Calcium and Vitamin D (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00386672?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00386672's enrollment target sits among peer trials
83 990th of 2000 higher than 1,011 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02974647 · 83 participants · Phase 2
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- NCT03919292 · 83 participants · Phase 1
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
- NCT04626674 · 83 participants · Phase 1
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)
- NCT05277168 · 83 participants · Phase 1
A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia